Emerging roles of P2X receptors in cancer. 2015

Elena Adinolfi, and Marina Capece, and Francesca Amoroso, and Elena De Marchi, and Alessia Franceschini

Tumor microenvironment composition strongly conditions cancer growth and progression, acting not only at cancer itself but also modifying its interactions with immune, endothelial and nervous cells. Extracellular ATP and its receptors recently gained increasing attention in the oncological field. ATP accumulates in cancer milieu through spontaneous release, tumor necrosis or chemotherapy exerting a trophic activity on cancer cells, modulating the cross talk among tumor, and surrounding tissues. Accordingly, ATP gated P2X receptors emerged as central players in tumor development, invasion, progression and related symptoms. Indeed, P2X receptors are expressed and are functional not only on tumor cells but also in immune-infiltrate and nearby neurons. In this review, we summarize recent findings on P2X receptors role in tumor cell differentiation, bioenergetics, angiogenesis, metastasis and associated pain, giving an outline of the potential anti-neoplastic activity of receptor agonists and antagonists.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D058469 Receptors, Purinergic P2X A subclass of purinergic P2 receptors that signal by means of a ligand-gated ion channel. They are comprised of three P2X subunits which can be identical (homotrimeric form) or dissimilar (heterotrimeric form). P2X Purinoceptor,P2X Purinoceptors,P2X Receptors, Purinergic,Purinergic P2X Receptors,Purinoceptor, P2X,Purinoceptors, P2X
D059016 Tumor Microenvironment The milieu surrounding neoplasms consisting of cells, vessels, soluble factors, and molecules, that can influence and be influenced by, the neoplasm's growth. Cancer Microenvironment,Cancer Microenvironments,Microenvironment, Cancer,Microenvironment, Tumor,Microenvironments, Cancer,Microenvironments, Tumor,Tumor Microenvironments
D018450 Disease Progression The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. Clinical Course,Clinical Progression,Disease Exacerbation,Exacerbation, Disease,Progression, Clinical,Progression, Disease

Related Publications

Elena Adinolfi, and Marina Capece, and Francesca Amoroso, and Elena De Marchi, and Alessia Franceschini
January 2013, Frontiers in physiology,
Elena Adinolfi, and Marina Capece, and Francesca Amoroso, and Elena De Marchi, and Alessia Franceschini
October 1996, The European journal of neuroscience,
Elena Adinolfi, and Marina Capece, and Francesca Amoroso, and Elena De Marchi, and Alessia Franceschini
January 2014, Annual review of physiology,
Elena Adinolfi, and Marina Capece, and Francesca Amoroso, and Elena De Marchi, and Alessia Franceschini
April 2017, Journal of molecular endocrinology,
Elena Adinolfi, and Marina Capece, and Francesca Amoroso, and Elena De Marchi, and Alessia Franceschini
January 1999, Proceedings of the Western Pharmacology Society,
Elena Adinolfi, and Marina Capece, and Francesca Amoroso, and Elena De Marchi, and Alessia Franceschini
January 2015, Current medicinal chemistry,
Elena Adinolfi, and Marina Capece, and Francesca Amoroso, and Elena De Marchi, and Alessia Franceschini
January 2015, Advances in cancer research,
Elena Adinolfi, and Marina Capece, and Francesca Amoroso, and Elena De Marchi, and Alessia Franceschini
August 2016, Biochimica et biophysica acta,
Elena Adinolfi, and Marina Capece, and Francesca Amoroso, and Elena De Marchi, and Alessia Franceschini
May 2021, Biochemical pharmacology,
Elena Adinolfi, and Marina Capece, and Francesca Amoroso, and Elena De Marchi, and Alessia Franceschini
November 2014, World journal of biological chemistry,
Copied contents to your clipboard!